| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242
Address all correspondence and requests for reprints to: Jeffrey E. Pessin, The Department of Physiology and Biophysics, The University of Iowa, Iowa City, Iowa 52242-1109. E-mail: Jeffrey-Pessin{at}UIOWA.EDU
In contrast to the 52-kDa Shc isoform, insulin stimulation caused a quantitative, time-dependent decrease in the SDS-PAGE mobility of 66-kDa Shc in both Chinese hamster ovary/IR cells and 3T3L1 adipocytes. Alkaline phosphatase treatment and direct phosphoamino acid analysis demonstrated that insulin stimulated an increase in serine phosphorylation of the 66-kDa isoform but not 52-kDa Shc, although the latter displayed a marked increase in tyrosine phosphorylation. To identify the responsible kinase pathway, we compared the effects on 66-kDa Shc serine phosphorylation by insulin, anisomycin, and osmotic shock, agents that specifically activate the ERK, JNK, or both pathways, respectively. Insulin and osmotic shock both stimulated a decrease in 66-kDa Shc mobility, whereas anisomycin had no effect. Furthermore, expression of a dominant-interfering Ras mutant (N17Ras) prevented the insulin-stimulated, but not the osmotic shock-induced serine phosphorylation of 66-kDa Shc. Consistent with a MEK-dependent pathway mediating 66-kDa Shc serine phosphorylation, the specific MEK inhibitor (PD98059) and expression of a dominant-interfering MEK mutant partially inhibited both the insulin and osmotic shock-induced reduction in 66-kDa Shc mobility. In contrast, expression of the MAP kinase phosphatase (MKP-1) completely prevented ERK activation but did not inhibit the serine phosphorylation of 66-kDa Shc. These data demonstrate that insulin stimulates the serine phosphorylation of the 66-kDa Shc isoform through a MEK-dependent mechanism.
This article has been cited by other articles:
![]() |
M. A. Bogoyevitch and B. Kobe Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1061 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity J. Cell Biol., April 25, 2005; 169(2): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro Diabetes Induces p66shc Gene Expression in Human Peripheral Blood Mononuclear Cells: Relationship to Oxidative Stress J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natalicchio, L. Laviola, C. De Tullio, L. A. Renna, C. Montrone, S. Perrini, G. Valenti, G. Procino, M. Svelto, and F. Giorgino Role of the p66Shc Isoform in Insulin-like Growth Factor I Receptor Signaling through MEK/Erk and Regulation of Actin Cytoskeleton in Rat Myoblasts J. Biol. Chem., October 15, 2004; 279(42): 43900 - 43909. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Zinker, C. M. Rondinone, J. M. Trevillyan, R. J. Gum, J. E. Clampit, J. F. Waring, N. Xie, D. Wilcox, P. Jacobson, L. Frost, et al. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice PNAS, August 20, 2002; 99(17): 11357 - 11362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Faisal, M. El-Shemerly, D. Hess, and Y. Nagamine Serine/Threonine Phosphorylation of ShcA. REGULATION OF PROTEIN-TYROSINE PHOSPHATASE-PEST BINDING AND INVOLVEMENT IN INSULIN SIGNALING J. Biol. Chem., August 9, 2002; 277(33): 30144 - 30152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ventura, L. Luzi, S. Pacini, C. T. Baldari, and P. G. Pelicci The p66Shc Longevity Gene Is Silenced through Epigenetic Modifications of an Alternative Promoter J. Biol. Chem., June 14, 2002; 277(25): 22370 - 22376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. H. Yang and S. B. Horwitz Taxol Mediates Serine Phosphorylation of the 66-kDa Shc Isoform Cancer Res., September 1, 2000; 60(18): 5171 - 5178. [Abstract] [Full Text] |
||||
![]() |
L. D. Klaman, O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M. Zabolotny, N. Moghal, M. Lubkin, Y.-B. Kim, A. H. Sharpe, et al. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice Mol. Cell. Biol., August 1, 2000; 20(15): 5479 - 5489. [Abstract] [Full Text] |
||||
![]() |
F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo, A. Costantino, I. D. Goldfine, A. Belfiore, and R. Vigneri Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells Mol. Cell. Biol., May 1, 1999; 19(5): 3278 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsakiridis, A. Bergman, R. Somwar, C. Taha, K. Aktories, T. F. Cruz, A. Klip, and G. P. Downey Actin Filaments Facilitate Insulin Activation of the Src and Collagen Homologous/Mitogen-activated Protein Kinase Pathway Leading to DNA Synthesis and c-fos Expression J. Biol. Chem., October 23, 1998; 273(43): 28322 - 28331. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Ceresa, A. W. Kao, S. R. Santeler, and J. E. Pessin Inhibition of Clathrin-Mediated Endocytosis Selectively Attenuates Specific Insulin Receptor Signal Transduction Pathways Mol. Cell. Biol., July 1, 1998; 18(7): 3862 - 3870. [Abstract] [Full Text] |
||||
![]() |
P. J. Antoine, F. Bertrand, M. Auclair, J. Magre, J. Capeau, and G. Cherqui Insulin Induction of Protein Kinase C{alpha} Expression Is Independent of Insulin Receptor Tyr1162/1163 Residues and Involves Mitogen-Activated Protein Kinase Kinase 1 and Sustained Activation of Nuclear p44MAPK Endocrinology, July 1, 1998; 139(7): 3133 - 3142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murasawa, Y. Mori, Y. Nozawa, N. Gotoh, M. Shibuya, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Moriguchi, Y. Shibazaki, et al. Angiotensin II Type 1 Receptor–Induced Extracellular Signal–Regulated Protein Kinase Activation Is Mediated by Ca2+/Calmodulin-Dependent Transactivation of Epidermal Growth Factor Receptor Circ. Res., June 29, 1998; 82(12): 1338 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Love, A. J. Whatmore, P. E. Clayton, and C. M. Silva Growth Hormone Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Cell Type Specific Endocrinology, April 1, 1998; 139(4): 1965 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okada, A. W. Kao, B. P. Ceresa, P. Blaikie, B. Margolis, and J. E. Pessin The 66-kDa Shc Isoform Is a Negative Regulator of the Epidermal Growth Factor-stimulated Mitogen-activated Protein Kinase Pathway J. Biol. Chem., October 31, 1997; 272(44): 28042 - 28049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Foschi, F. Franchi, J. Han, G. L. Villa, and A. Sorokin Endothelin-1 Induces Serine Phosphorylation of the Adaptor Protein p66Shc and Its Association with 14-3-3 Protein in Glomerular Mesangial Cells J. Biol. Chem., July 6, 2001; 276(28): 26640 - 26647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |